Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Intervertebral Disc Disease Clinical Trial

Official title:
Clinical Trial Phase I / II Prospective, Open, Non-randomized for Treatment of Lumbar Intervertebral Degenerative Disc Disease With Posterolateral Instrumented and Autologous Mesenchymal Stem Cells.

Status Completed

Clinical Trial Summary

The purpose of this trial is to test the effectiveness of the use of a new therapeutic strategy in treating patients with degenerative disc disease lumbar intervertebral fusion with instrumented posterolateral autologous mesenchymal stem cells and arranged in a calcium phosphate ceramic (Conduit TM).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01513694
Study type	Interventional
Source	Red de Terapia Celular
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	January 2010
Completion date	May 4, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01941563` - A Study of SI-6603 in Patients With Lumbar Disc Herniation	Phase 3
Completed	`NCT02931279` - PASS OCT® Post-market Clinical Follow-up
Completed	`NCT02225444` - A Prospective Study of Instrumented, Posterolateral Lumbar Fusions (PLF) With OsteoAMP®
Completed	`NCT02421601` - A Study of SI-6603 in Patients With Lumbar Disc Herniation	Phase 3
Terminated	`NCT02381067` - A Prospective Study of NuCel® in Cervical Spine Fusion	N/A
Completed	`NCT01860417` - Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)	Phase 1/Phase 2
Completed	`NCT03018392` - Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage	N/A
Completed	`NCT02023372` - Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine	N/A